Anteris Technologies Global (AVR) Return on Invested Capital (2025 - 2026)

Anteris Technologies Global's (AVR) quarterly Return on Invested Capital came in at 0.64% in Q1 2026, up 127.0% year-on-year from 0.28% in Q1 2025, and down 1.89% on a QoQ basis from 0.63% in Q4 2025.

Anteris Technologies Global (AVR) Return on Invested Capital (2025 - 2026) Analysis & Trends

Anteris Technologies Global (AVR) has 2 years of Return on Invested Capital data on file, last reported at 0.64% in Q1 2026.

  • On a quarterly basis, Return on Invested Capital rose 127.0% year-over-year to 0.64% in Q1 2026; TTM through Mar 2026 was 0.64%, a 127.0% increase from a year earlier, with the FY2025 full-year figure at 78.08%, changed N/A from the prior year.
  • Return on Invested Capital for Q1 2026 stood at 0.64%, down from 0.63% in the prior quarter.
  • Over the last five years, Return on Invested Capital for AVR reached as high as 0.62% in Q3 2025 and fell as low as 1.9% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 0.00%
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 0.02%
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 0.00%
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 0.12%
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Anteris Technologies Global 679.85 Mn 679.82 Mn 380,000.00 -0.64%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.64%
Dec 31, 2025 -0.63%
Sep 30, 2025 -0.62%
Jun 30, 2025 -0.77%
Mar 31, 2025 -1.90%